{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:39:33Z","timestamp":1786995573753,"version":"build-2736575974"},"reference-count":70,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,5]],"date-time":"2024-09-05T00:00:00Z","timestamp":1725494400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100021856","name":"Ministero dell'Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100021856","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.phrs.2024.107403","type":"journal-article","created":{"date-parts":[[2024,9,10]],"date-time":"2024-09-10T12:36:42Z","timestamp":1725971802000},"page":"107403","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Development of dual GPBAR1 agonist and ROR\u03b3t inverse agonist for the treatment of inflammatory bowel diseases"],"prefix":"10.1016","volume":"208","author":[{"given":"Michele","family":"Biagioli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Di Giorgio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elva","family":"Morretta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachele","family":"Bellini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Massa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ginevra","family":"Urbani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Bordoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Marchian\u00f2","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ginevra","family":"Lachi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Sepe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Chiara","family":"Monti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleonora","family":"Distrutti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Zampella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Fiorucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.phrs.2024.107403_bib1","doi-asserted-by":"crossref","first-page":"2652","DOI":"10.1056\/NEJMra2002697","article-title":"Pathophysiology of inflammatory bowel diseases","volume":"383","author":"Chang","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.phrs.2024.107403_bib2","first-page":"3178","article-title":"Innate and adaptive immunity in inflammatory bowel disease","volume":"17","author":"Siegmund","year":"2011","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.phrs.2024.107403_bib3","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.autrev.2013.06.004","article-title":"Innate and adaptive immunity in inflammatory bowel disease","volume":"13","author":"Geremia","year":"2014","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.phrs.2024.107403_bib4","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1097\/MIB.0000000000000955","article-title":"An overview of the innate and adaptive immune system in inflammatory bowel disease","volume":"23","author":"Choy","year":"2017","journal-title":"Inflamm. Bowel Dis."},{"key":"10.1016\/j.phrs.2024.107403_bib5","first-page":"2490","article-title":"Inflammatory bowel disease related innate immunity and adaptive immunity","volume":"8","author":"Huang","year":"2016","journal-title":"Am. J. Transl. Res"},{"key":"10.1016\/j.phrs.2024.107403_bib6","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24021526","article-title":"Pathophysiology of inflammatory bowel disease: innate immune system","volume":"24","author":"Saez","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.phrs.2024.107403_bib7","doi-asserted-by":"crossref","DOI":"10.3390\/cells10061281","article-title":"Bile acids activated receptors in inflammatory bowel disease","volume":"10","author":"Biagioli","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.phrs.2024.107403_bib8","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1007\/s10620-020-06715-3","article-title":"Bile acid signaling in inflammatory bowel diseases","volume":"66","author":"Fiorucci","year":"2021","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.phrs.2024.107403_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.plipres.2021.101094","article-title":"Bile acids and their receptors in metabolic disorders","volume":"82","author":"Fiorucci","year":"2021","journal-title":"Prog. Lipid Res"},{"key":"10.1016\/j.phrs.2024.107403_bib10","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/S0006-291X(02)02550-0","article-title":"Identification of membrane-type receptor for bile acids (M-BAR)","volume":"298","author":"Maruyama","year":"2002","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.phrs.2024.107403_bib11","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0025637","article-title":"The bile acid receptor GPBAR-1 (TGR5) modulates integrity of intestinal barrier and immune response to experimental colitis","author":"Cipriani","year":"2011","journal-title":"PLoS One 6"},{"key":"10.1016\/j.phrs.2024.107403_bib12","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.bbadis.2009.04.004","article-title":"Reciprocal regulation of the bile acid-activated receptor FXR and the interferon-gamma-STAT-1 pathway in macrophages","volume":"1792","author":"Renga","year":"2009","journal-title":"Biochim Biophys. Acta"},{"key":"10.1016\/j.phrs.2024.107403_bib13","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1136\/gutjnl-2012-302578","article-title":"Connecting dysbiosis, bile-acid dysmetabolism and gut inflammation in inflammatory bowel diseases","volume":"62","author":"Duboc","year":"2013","journal-title":"Gut"},{"key":"10.1016\/j.phrs.2024.107403_bib14","doi-asserted-by":"crossref","first-page":"718","DOI":"10.4049\/jimmunol.1700183","article-title":"The Bile Acid Receptor GPBAR1 Regulates the M1\/M2 Phenotype of Intestinal Macrophages and Activation of GPBAR1 Rescues Mice from Murine Colitis","volume":"199","author":"Biagioli","year":"2017","journal-title":"J. Immunol."},{"key":"10.1016\/j.phrs.2024.107403_bib15","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/j.jhep.2010.12.004","article-title":"The bile acid membrane receptor TGR5 as an emerging target in metabolism and inflammation","volume":"54","author":"Pols","year":"2011","journal-title":"J. Hepatol."},{"key":"10.1016\/j.phrs.2024.107403_bib16","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/nm.4046","article-title":"Transient inhibition of ROR-\u03b3t therapeutically limits intestinal inflammation by reducing TH17 cells and preserving group 3 innate lymphoid cells","volume":"22","author":"Withers","year":"2016","journal-title":"Nat. Med"},{"key":"10.1016\/j.phrs.2024.107403_bib17","doi-asserted-by":"crossref","first-page":"10132","DOI":"10.1073\/pnas.97.18.10132","article-title":"Retinoid-related orphan receptor gamma (RORgamma) is essential for lymphoid organogenesis and controls apoptosis during thymopoiesis","volume":"97","author":"Kurebayashi","year":"2000","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.phrs.2024.107403_bib18","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1126\/science.1194597","article-title":"Lineage relationship analysis of RORgammat+ innate lymphoid cells","volume":"330","author":"Sawa","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.phrs.2024.107403_bib19","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.smim.2007.10.011","article-title":"Transcriptional regulation of Th17 cell differentiation","volume":"19","author":"Ivanov","year":"2007","journal-title":"Semin Immunol."},{"key":"10.1016\/j.phrs.2024.107403_bib20","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/j.cell.2006.07.035","article-title":"The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells","volume":"126","author":"Ivanov","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.phrs.2024.107403_bib21","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/s41586-019-1785-z","article-title":"Bile acid metabolites control T","volume":"576","author":"Hang","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.phrs.2024.107403_bib22","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1038\/s41586-021-03832-5","article-title":"Novel bile acid biosynthetic pathways are enriched in the microbiome of centenarians","volume":"599","author":"Sato","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.phrs.2024.107403_bib23","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/nri.2016.36","article-title":"Development and maintenance of intestinal regulatory T cells","volume":"16","author":"Tanoue","year":"2016","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.phrs.2024.107403_bib24","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/s41586-019-1785-z","article-title":"Bile acid metabolites control T(H)17 and T(reg) cell differentiation.","volume":"576","author":"Hang","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.phrs.2024.107403_bib25","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1038\/s41586-020-2193-0","article-title":"Bacterial metabolism of bile acids promotes generation of peripheral regulatory T cells","volume":"581","author":"Campbell","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.phrs.2024.107403_bib26","doi-asserted-by":"crossref","DOI":"10.1038\/s41586-020-2030-5","article-title":"Author correction: bile acid metabolites control T","volume":"579","author":"Hang","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.phrs.2024.107403_bib27","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1038\/s41586-019-1865-0","article-title":"Microbial bile acid metabolites modulate gut ROR\u03b3(+) regulatory T cell homeostasis","volume":"577","author":"Song","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.phrs.2024.107403_bib28","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1016\/j.ajpath.2020.07.010","article-title":"Retinoid-related orphan receptor ROR\u03b3t in CD4(+) T-cell-mediated intestinal homeostasis and inflammation","volume":"190","author":"Mickael","year":"2020","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.phrs.2024.107403_bib29","doi-asserted-by":"crossref","DOI":"10.3390\/cells9010110","article-title":"Dissecting the heterogeneity in T-Cell mediated inflammation in IBD","volume":"9","author":"Tindemans","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.phrs.2024.107403_bib30","doi-asserted-by":"crossref","first-page":"1055914","DOI":"10.3389\/fimmu.2022.1055914","article-title":"The role of Th17 cells in inflammatory bowel disease and the research progress","volume":"13","author":"Chen","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.phrs.2024.107403_bib31","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1111\/j.1365-2230.2005.01786.x","article-title":"Composite cutaneous haemangioendothelioma: case report and review of the literature","volume":"30","author":"Biagioli","year":"2005","journal-title":"Clin. Exp. Dermatol."},{"key":"10.1016\/j.phrs.2024.107403_bib32","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1038\/ni1254","article-title":"Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages.","volume":"6","author":"Harrington","year":"2005","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.phrs.2024.107403_bib33","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.immuni.2007.11.016","article-title":"T helper 17 lineage differentiation is programmed by orphan nuclear receptors ROR alpha and ROR gamma","volume":"28","author":"Yang","year":"2008","journal-title":"Immunity"},{"key":"10.1016\/j.phrs.2024.107403_bib34","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.cotox.2018.01.005","article-title":"Retinoic acid-related Orphan Receptor \u03b3 (ROR\u03b3): connecting sterol metabolism to regulation of the immune system and autoimmune disease","volume":"8","author":"Jetten","year":"2018","journal-title":"Curr. Opin. Toxicol."},{"key":"10.1016\/j.phrs.2024.107403_bib35","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1038\/s41586-019-1237-9","article-title":"Multi-omics of the gut microbial ecosystem in inflammatory bowel diseases","volume":"569","author":"Lloyd-Price","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.phrs.2024.107403_bib36","doi-asserted-by":"crossref","first-page":"5983","DOI":"10.1021\/acsomega.2c07907","article-title":"Discovery of a novel class of dual GPBAR1 agonists-ROR\u03b3t inverse agonists for the treatment of IL-17-mediated disorders.","volume":"8","author":"Fiorillo","year":"2023","journal-title":"ACS Omega"},{"key":"10.1016\/j.phrs.2024.107403_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2023.115776","article-title":"Development of bile acid activated receptors hybrid molecules for the treatment of inflammatory and metabolic disorders","volume":"216","author":"Fiorucci","year":"2023","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.phrs.2024.107403_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2021.114564","article-title":"Discovery of a AHR pelargonidin agonist that counter-regulates Ace2 expression and attenuates ACE2-SARS-CoV-2 interaction","volume":"188","author":"Biagioli","year":"2021","journal-title":"Biochem Pharm."},{"key":"10.1016\/j.phrs.2024.107403_bib39","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1002\/1097-0320(20011101)45:3<194::AID-CYTO1163>3.0.CO;2-C","article-title":"Spectral compensation for flow cytometry: visualization artifacts, limitations, and caveats","volume":"45","author":"Roederer","year":"2001","journal-title":"Cytometry"},{"key":"10.1016\/j.phrs.2024.107403_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2023.115900","article-title":"Activation of GPBAR1 attenuates vascular inflammation and atherosclerosis in a mouse model of NAFLD-related cardiovascular disease","volume":"218","author":"Biagioli","year":"2023","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.phrs.2024.107403_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2024.116134","article-title":"Bile acids serve as endogenous antagonists of the Leukemia inhibitory factor (LIF) receptor in oncogenesis","volume":"223","author":"Di Giorgio","year":"2024","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.phrs.2024.107403_bib42","doi-asserted-by":"crossref","first-page":"6","DOI":"10.3748\/wjg.v20.i1.6","article-title":"Immunopathology of inflammatory bowel disease","volume":"20","author":"Wallace","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.phrs.2024.107403_bib43","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1002\/ibd.20894","article-title":"Interleukin-23\/Th17 pathways and inflammatory bowel disease","volume":"15","author":"Abraham","year":"2009","journal-title":"Inflamm. Bowel Dis."},{"key":"10.1016\/j.phrs.2024.107403_bib44","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1007\/s10620-015-3622-z","article-title":"E-cadherin is important for the maintenance of intestinal epithelial homeostasis under basal and inflammatory conditions","volume":"60","author":"Schnoor","year":"2015","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.phrs.2024.107403_bib45","doi-asserted-by":"crossref","unstructured":"F.S. Biagioli M., Di Giorgio C., Massa C., Marchian\u00f2 S., Bellini R., Bordoni M., Urbani G., Roselli R., Lachi G., Morretta E., Dal Piaz F., Charlier B., Fiorillo B., Catalanotti B., Cari L., Nocentini G., Ricci P., Distrutti E., Sepe V., Zampella A., Monti MC, A microbial derived bile acid acts as GPBAR1 agonist and ROR\u03b3t inverse agonist and reverses inflammation in inflammatory bowel disease, BioRxiv. (2024).","DOI":"10.1101\/2024.04.08.588556"},{"key":"10.1016\/j.phrs.2024.107403_bib46","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.1016\/S0140-6736(17)32448-0","article-title":"Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies","volume":"390","author":"Ng","year":"2017","journal-title":"Lancet (Lond., Engl. )"},{"key":"10.1016\/j.phrs.2024.107403_bib47","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/S2468-1253(21)00065-0","article-title":"Breaking the therapeutic ceiling in drug development in ulcerative colitis","volume":"6","author":"Alsoud","year":"2021","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"10.1016\/j.phrs.2024.107403_bib48","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1038\/s41573-024-00953-0","article-title":"Navigating the complexities of drug development for inflammatory bowel disease","volume":"23","author":"Honap","year":"2024","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.phrs.2024.107403_bib49","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/ng.3755","article-title":"Genome-wide association study identifies distinct genetic contributions to prognosis and susceptibility in Crohn\u2019s disease","volume":"49","author":"Lee","year":"2017","journal-title":"Nat. Genet."},{"key":"10.1016\/j.phrs.2024.107403_bib50","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.livres.2021.08.003","article-title":"Bile acid activated receptors: integrating immune and metabolic regulation in non-alcoholic fatty liver disease","volume":"5","author":"Biagioli","year":"2021","journal-title":"Liver Res"},{"key":"10.1016\/j.phrs.2024.107403_bib51","doi-asserted-by":"crossref","DOI":"10.11131\/2015\/101185","article-title":"Retinoic acid-related orphan receptors (RORs): regulatory functions in immunity, development, circadian rhythm, and metabolism","volume":"2","author":"Cook","year":"2015","journal-title":"Nucl. Recept. Res."},{"key":"10.1016\/j.phrs.2024.107403_bib52","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/s41575-023-00784-1","article-title":"A roadmap for the human gut cell atlas","volume":"20","author":"Zilbauer","year":"2023","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.phrs.2024.107403_bib53","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/nrgastro.2017.110","article-title":"The IBD interactome: an integrated view of aetiology, pathogenesis and therapy","volume":"14","author":"de Souza","year":"2017","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.phrs.2024.107403_bib54","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.611256","article-title":"The IL23-IL17 immune axis in the treatment of ulcerative colitis: successes, defeats, and ongoing challenges","volume":"12","author":"Noviello","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.phrs.2024.107403_bib55","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1136\/gut.2007.135053","article-title":"IL23 differentially regulates the Th1\/Th17 balance in ulcerative colitis and Crohn\u2019s disease","volume":"57","author":"Kobayashi","year":"2008","journal-title":"Gut"},{"key":"10.1016\/j.phrs.2024.107403_bib56","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1097\/MIB.0b013e318286fa1c","article-title":"TH17 cell induction and effects of IL-17A and IL-17F blockade in experimental colitis","volume":"19","author":"Wedebye Schmidt","year":"2013","journal-title":"Inflamm. Bowel Dis."},{"key":"10.1016\/j.phrs.2024.107403_bib57","doi-asserted-by":"crossref","DOI":"10.1136\/annrheumdis-2020-218719","article-title":"Paradoxical gastrointestinal effects of interleukin-17 blockers","volume":"82","author":"Mehta","year":"2023","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.phrs.2024.107403_bib58","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1124628","article-title":"IL-17 inhibitor-associated inflammatory bowel disease: A study based on literature and database analysis","volume":"14","author":"Deng","year":"2023","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.phrs.2024.107403_bib59","doi-asserted-by":"crossref","first-page":"989","DOI":"10.3892\/ijmm.2013.1287","article-title":"Aberrant expression of circulating Th17, Th1 and Tc1 cells in patients with active and inactive ulcerative colitis","volume":"31","author":"Dong","year":"2013","journal-title":"Int J. Mol. Med"},{"key":"10.1016\/j.phrs.2024.107403_bib60","doi-asserted-by":"crossref","first-page":"639","DOI":"10.3389\/fimmu.2015.00639","article-title":"The Treg\/Th17 axis: a dynamic balance regulated by the gut microbiome","volume":"6","author":"Omenetti","year":"2015","journal-title":"Front. Immunol."},{"key":"10.1016\/j.phrs.2024.107403_bib61","doi-asserted-by":"crossref","first-page":"6313","DOI":"10.4049\/jimmunol.1001454","article-title":"Th17 cells induce colitis and promote Th1 cell responses through IL-17 induction of innate IL-12 and IL-23 production","volume":"186","author":"Feng","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.phrs.2024.107403_bib62","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1136\/gut.2008.163667","article-title":"Crohn\u2019s disease: Th1, Th17 or both? The change of a paradigm: new immunological and genetic insights implicate Th17 cells in the pathogenesis of Crohn\u2019s disease","volume":"58","author":"Brand","year":"2009","journal-title":"Gut"},{"key":"10.1016\/j.phrs.2024.107403_bib63","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1111\/j.1365-2567.2011.03454.x","article-title":"Interleukin-23 and T helper 17-type responses in intestinal inflammation: from cytokines to T-cell plasticity","volume":"133","author":"Morrison","year":"2011","journal-title":"Immunology"},{"key":"10.1016\/j.phrs.2024.107403_bib64","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.immuni.2010.08.010","article-title":"Interleukin-23 drives intestinal inflammation through direct activity on T cells","volume":"33","author":"Ahern","year":"2010","journal-title":"Immunity"},{"key":"10.1016\/j.phrs.2024.107403_bib65","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.4049\/jimmunol.1901427","article-title":"The bile acid receptor GPBAR1 modulates CCL2\/CCR2 signaling at the liver sinusoidal\/macrophage interface and reverses acetaminophen-induced liver toxicity","volume":"204","author":"Biagioli","year":"2020","journal-title":"J. Immunol."},{"key":"10.1016\/j.phrs.2024.107403_bib66","doi-asserted-by":"crossref","DOI":"10.1016\/j.plipres.2024.101291","article-title":"Immunology of bile acids regulated receptors","volume":"95","author":"Fiorucci","year":"2024","journal-title":"Prog. Lipid Res."},{"key":"10.1016\/j.phrs.2024.107403_bib67","article-title":"The role of group 3 innate lymphoid cell in intestinal disease","volume":"14","author":"Li","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.phrs.2024.107403_bib68","doi-asserted-by":"crossref","DOI":"10.3390\/cells11071187","article-title":"GLP-1 Mediates Regulation of Colonic ACE2 Expression by the Bile Acid Receptor GPBAR1 in Inflammation","volume":"11","author":"Biagioli","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.phrs.2024.107403_bib69","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1016\/j.cmet.2024.05.001","article-title":"Glucagon-like peptide 1 receptor is a T cell-negative costimulatory molecule","volume":"36","author":"Ben Nasr","year":"2024","journal-title":"Cell Metab."},{"key":"10.1016\/j.phrs.2024.107403_bib70","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2020.05.067","article-title":"Bile acids signal via TGR5 to activate intestinal stem cells and epithelial regeneration","volume":"159","author":"Sorrentino","year":"2020","journal-title":"Gastroenterology"}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661824003487?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661824003487?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,18]],"date-time":"2024-09-18T10:01:10Z","timestamp":1726653670000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661824003487"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":70,"alternative-id":["S1043661824003487"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2024.107403","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of dual GPBAR1 agonist and ROR\u03b3t inverse agonist for the treatment of inflammatory bowel diseases","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2024.107403","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"107403"}}